mm

About Jason Novak

Jason has been a consistent contributor to VectorVest and has a blended interest in technology and finance, which he has written about for over a decade. When he's not demystifying complex financial topics or sharing a quick analysis of hot stocks on a given day, you may find him on the golf course or exploring all that Northern California has to offer.
25 04, 2023

Can JAKKS Pacific, Inc. Exceed Its September 2022 All-Time Highs?

By |2023-12-07T20:56:51+00:00April 25th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , |

The stock market can be a fickle beast, as evidenced by the recent tumultuous ride of JAKKS Pacific, Inc. (JAKK: Nasdaq). After reaching a record high of $27.87 on September 12, 2022, the stock plummeted to $16.79 on October 28, causing consternation among investors. In the ensuing months, the stock price experienced a series [...]

25 04, 2023

Fox News Stock Drops Dramatically After Tucker Carlson Exit – But is it as Bad as it Seems?

By |2023-12-07T20:56:53+00:00April 25th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

Fox News (FOX) shook the news world up Monday morning announcing long-standing host Tucker Carlson’s departure from the network. As a result, FOX shares dropped nearly 5% in yesterday’s trading sessions, resulting in a $962 million loss in market value. The company’s press release claims this was a mutual parting, but it’s generally believed [...]

24 04, 2023

Super Micro Drops 6% on Warnings of Missing Forecast: 3 Reasons We Still Like This Stock

By |2023-12-07T20:56:57+00:00April 24th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

Early Monday morning, Super Micro (SMCI) issued a warning that the company is going to fall short of its fiscal third-quarter revenue forecast. As a result, the company dropped as much as 12% in pre-market trading and now sits 6% lower than it opened at. While Super Micro originally issued a March-quarter revenue guidance [...]

21 04, 2023

AT&T’s Weak Q1 Leads to 10% Drop: Is This an Overreaction or a Sign of What’s to Come?

By |2023-12-07T20:57:02+00:00April 21st, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Yesterday, AT&T (T) posted 1st quarter earnings that left much to be desired. While subscriber growth was up, revenue was down - and the market reacted by sending shares down more than 10% in Thursday’s trading session. A key indicator of the telecommunication company’s well-being is postpaid phone plans - a figure representing the [...]

20 04, 2023

Tesla’s Profitability Woes From Q1 Will Worsen on the Road Ahead – is it Time to Get Out?

By |2023-12-07T20:57:05+00:00April 20th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

It’s been a tough morning for Elon Musk, as not only did SpaceX Starship fail mid-flight - Tesla’s (TSLA) 1st quarter earnings came in overnight and the response has been anything but positive. The company is in the pits of a profitability battle that resulted in a drop to 11.4% in operating margin. This [...]

19 04, 2023

The Inside Scoop on Morgan Stanley’s Q1 Performance and Its Implications for Traders

By |2023-12-07T20:57:10+00:00April 19th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , |

Morgan Stanley (MS) joined other investment banking companies in reporting a lackluster first quarter - one that saw a decline in revenue and profit figures. The company fell victim to a steep drop-off in investment banking revenue, as deals dried up amidst a challenging economic environment. Revenue for the quarter fell 2% from this [...]

18 04, 2023

Amneal Pharma Issues Guidance Over Market Forecasts, But We See 3 Things Holding the Stock Back

By |2023-12-07T20:57:13+00:00April 18th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

Yesterday, Amneal Pharmaceuticals (AMRX) issued guidance for the first quarter of 2023 that came in over the consensus estimates. This sent shares trading as much as 14% higher in premarket trading. The stock opened Monday’s trading session at $1.34/share and closed at $1.63 for a nice single-day gain. The pharmaceutical company says that revenue [...]

17 04, 2023

Coors Stock Climbs Amidst Bud Light Controversy: Does it Belong in Your Portfolio, Though?

By |2023-12-07T20:57:15+00:00April 17th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

Anheuser-Busch - the parent company for Bud Light - has made nationwide waves with its latest promotional marketing tactic. After partnering with transgender influencer Dylan Mulvaney, the company has received a barrage of criticism. While BUD stock is down in the past week, the company’s competitors are thriving - one of which is Molson [...]

Go to Top